Clinical Trial Update: Preventing Antibiotic-Associated DiarRhea Using Erceflora [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Erceflora to prevent antibiotic-associated diarrhea in infants has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infantile Diarrhea

Drugs mentioned

• Erceflora

Snippet

Sponsor: Sanofi | Conditions: Diarrhea, Infantile | Phase 4 | Status: COMPLETED